Chemotherapy first approach reduces risk of colon cancer return

Getty/FatCamera

Chemotherapy before surgery reduces the risk of colon cancer returning in two years by 28%, according to a new study.

The FOxTROT trial, led by scientists at the University of Birmingham and the University of Leeds, involved 1,053 colon cancer patients from 85 hospitals in the UK, Denmark and Sweden.